A detailed history of Qube Research & Technologies LTD transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,789,237 shares of PACB stock, worth $2.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,789,237
Holding current value
$2.45 Million
% of portfolio
0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.52 - $9.59 $6.3 Million - $17.2 Million
1,789,237 New
1,789,237 $6.71 Million
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $2.23 Million - $3.77 Million
270,573 Added 452.78%
330,331 $2.76 Million
Q2 2023

Aug 14, 2023

SELL
$9.97 - $14.05 $879,184 - $1.24 Million
-88,183 Reduced 59.61%
59,758 $794,000
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $4.22 Million - $6.39 Million
-531,332 Reduced 78.22%
147,941 $1.71 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $3.85 Million - $7.61 Million
679,273 New
679,273 $5.56 Million
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $288,262 - $747,904
-71,707 Reduced 65.13%
38,385 $170,000
Q1 2022

May 09, 2022

BUY
$8.43 - $20.9 $928,075 - $2.3 Million
110,092 New
110,092 $1 Million
Q2 2021

Aug 13, 2021

SELL
$22.3 - $36.02 $1.5 Million - $2.42 Million
-67,267 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$26.38 - $51.15 $759,242 - $1.47 Million
28,781 Added 74.78%
67,267 $2.24 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $404,103 - $1.1 Million
38,486 New
38,486 $998,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $264,556 - $589,646
-112,100 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$4.6 - $5.57 $515,659 - $624,397
112,100 New
112,100 $576,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $308M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.